XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS' EQUITY (Tables)
 9 Months Ended
Sep. 30, 2025
Stockholders' Equity Note [Abstract]  
Schedule of Compensation Cost on Net Earnings
The Company’s results for the three and nine months ended September 30, 2025 and 2024 reflected the following stock-based compensation cost, and such compensation cost had the following effects on net earnings:

Increase/(Decrease) for theIncrease/(Decrease) for the
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Cost of sales$382 $441 $1,356 $1,266 
Operating expenses4,268 3,710 12,942 11,521 
Net earnings(3,626)(3,188)(11,131)(9,815)
Schedule of Stock Option Activity
Option activity for the nine months ended September 30, 2025 and 2024 is summarized below:
For the Nine Months Ended September 30, 2025Shares (000s)Weighted
Average
Exercise
Price		Aggregate
Intrinsic
Value		Weighted
Average
Remaining
Contractual
Term
Outstanding as of December 31, 2024962 $114.81 $46,346 
Granted51 159.18 
Exercised(76)90.46 
Forfeited(3)142.33 
Canceled(1)139.81 
Outstanding as of September 30, 2025933 $119.11 $29,374 5.4
Exercisable as of September 30, 2025661 $108.04 $27,784 4.3
For the Nine Months Ended September 30, 2024Shares (000s)Weighted
Average
Exercise
Price		Aggregate
Intrinsic
Value		Weighted
Average
Remaining
Contractual
Term
Outstanding as of December 31, 20231,078 $104.38 $47,889 
Granted113 143.43 
Exercised(198)75.94 
Forfeited(2)137.06 
Canceled— — 
Outstanding as of September 30, 2024991 $114.49 $60,932 6.0
Exercisable as of September 30, 2024626 $99.39 $47,926 4.6
Schedule of Other Information Pertaining to Stock Option Activity
Other information pertaining to option activity during the three and nine months ended September 30, 2025 and 2024 is as follows:

 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
Weighted-average fair value of options granted$— $— $48.86 $44.52 
Total intrinsic value of stock options exercised ($000s)$621 $5,372 $5,380 $16,693 
Schedule of Non-vested Restricted Stock Activity
Non-vested restricted stock activity for the nine months ended September 30, 2025 and 2024 is summarized below:
Nine Months Ended September 30,
20252024
Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance as of December 31122 $141.62 116 $133.06 
Granted65 158.89 50 147.49 
Vested(34)137.78 (34)120.01 
Forfeited(3)148.11 (3)141.23 
Non-vested balance as of September 30150 $149.84 129 $141.94 
Schedule of Non-vested Performance Share Activity
Non-vested performance share activity for the nine months ended September 30, 2025 and 2024 is summarized below:

Nine Months Ended September 30,
20252024
Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance as of December 3179 $150.73 76 $135.25 
Granted50 147.96 47 152.28
Vested(44)130.29 (44)106.57
Forfeited(4)152.69 — —
Non-vested balance as of September 3081 $160.14 79 $150.73